Financials
Income statement
| Fiscal date | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|
| Total reported revenue | 36.4B | 36.8B | 31.8B | 30.9B |
| Cost of revenue | 4.7B | 37.8B | 5.1B | 4.5B |
| Gross profit | 31.7B | -1B | 26.7B | 26.4B |
| Operating expense | ||||
| Research & development | — | — | — | — |
| Selling general and admin | 8.0B | 12.4B | 7.5B | 7.4B |
| Other operating expenses | 12.6B | -19.7B | 11.9B | 12.5B |
| Operating income | 5.6B | 4.8B | 1.5B | 980M |
| Non operating interest income | ||||
| Income | — | — | — | — |
| Expense | 1.1B | 1.0B | 1.0B | 980M |
| Other income expense | — | — | — | — |
| Pretax income | 5.2B | 4.7B | 830M | 730M |
| Tax provision | 1.2B | 280M | 170M | 240M |
| Net income | 4.0B | 4.4B | 660M | 490M |
| Basic EPS | 21.0 | — | 3.3 | 2.5 |
| Diluted EPS | 21.0 | — | 3.3 | 2.5 |
| Basic average shares | 187.6M | — | 187.7M | 187.8M |
| Diluted average shares | 187.6M | — | 187.7M | 187.8M |
| EBITDA | 9.3B | 7.8B | 5.5B | 5.1B |
| Net income from continuing op. | — | — | — | — |
| Minority interests | -20M | -40M | -50M | -30M |
| Preferred stock dividends | 0 | 0 | 0 | 0 |